These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21562439)

  • 1. Bilateral upper eyelid retraction caused by topical bimatoprost therapy.
    Noma K; Kakizaki H
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):e33-5. PubMed ID: 21562439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
    Inoue K; Shiokawa M; Wakakura M; Tomita G
    J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral deepening of upper lid sulcus from topical bimatoprost therapy.
    Yam JC; Yuen NS; Chan CW
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):471-2. PubMed ID: 19857110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost.
    Aihara M; Shirato S; Sakata R
    Jpn J Ophthalmol; 2011 Nov; 55(6):600-4. PubMed ID: 21953485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periocular changes in topical bimatoprost and latanoprost use.
    Karslioğlu MZ; Hoşal MB; Tekeli O
    Turk J Med Sci; 2015; 45(4):925-30. PubMed ID: 26422869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
    Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
    Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
    Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost.
    Sakata R; Shirato S; Miyata K; Aihara M
    Jpn J Ophthalmol; 2013 Mar; 57(2):179-84. PubMed ID: 23233196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deepening of lid sulcus from topical bimatoprost therapy.
    Peplinski LS; Albiani Smith K
    Optom Vis Sci; 2004 Aug; 81(8):574-7. PubMed ID: 15300114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periorbital changes associated with topical bimatoprost.
    Filippopoulos T; Paula JS; Torun N; Hatton MP; Pasquale LR; Grosskreutz CL
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):302-7. PubMed ID: 18645437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost.
    Nakakura S; Tabuchi H; Kiuchi Y
    Optom Vis Sci; 2011 Sep; 88(9):1140-4. PubMed ID: 21666524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.
    Park J; Cho HK; Moon JI
    Jpn J Ophthalmol; 2011 Jan; 55(1):22-7. PubMed ID: 21331688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased periocular pigmentation with ocular hypotensive lipid use in African Americans.
    Herndon LW; Robert D Williams ; Wand M; Asrani S
    Am J Ophthalmol; 2003 May; 135(5):713-5. PubMed ID: 12719085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.
    Sira M; Verity DH; Malhotra R
    Aesthet Surg J; 2012 Sep; 32(7):822-4. PubMed ID: 22942109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse periocular reactions to five types of prostaglandin analogs.
    Inoue K; Shiokawa M; Higa R; Sugahara M; Soga T; Wakakura M; Tomita G
    Eye (Lond); 2012 Nov; 26(11):1465-72. PubMed ID: 23037910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
    Nixon DR
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
    Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact dermatitis caused by latanoprost-containing eye drops with good tolerance to bimatoprost eye drops.
    Pérez-Rodríguez E; González-Pérez R; Poza P; Feliciano L; López-Correcher B; Matheu V
    Contact Dermatitis; 2008 Jun; 58(6):370-1. PubMed ID: 18503690
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.
    Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
    Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.